Abstract 4491: The mesenchymal subtype biomarkers arise from stroma rather than cancer cells in ovarian cancer
Authors: Qing Zhang, Kimberly R. Kalli, Chen Wang, William Cliby
Journal: Cancer Research (2018)

Abstract Background: High Grade Serous Ovarian Cancer (HGSOC) is a highly aggressive form of ovarian cancer accounting for up to 70% of all cases. The Cancer Genome Atlas (TCGA) has further defined 4 molecular subtypes within HGSOC: differentiated (DIF), immunoreactive (IMM), mesenchymal (MES), and proliferative (PRO). The MES subtype is associated with the worst prognosis and the least likely to be completely resectable when compared with other subtypes. A recent study suggested the existence of a 5-th, so-called anti-mesenchymal (ANM), subtype which is characterized by down-regulation of genes typically upregulated in the MES subtype. Importantly, previous molecular subtype studies have been performed using tumor samples consisting of both cancer cells and stroma. However, the origin of MES biomarkers in OC is still largely unknown and several studies suggest that many of the MES biomarkers could arise from cancer-associated stroma rather than cancer cells. Methods: Specimens from 20 patients (MES subtype, n=15; ANM subtype, n=5) diagnosed with HGSOC between 2010 and 2013 were obtained from Pathology Research Core in Mayo Clinic. A total of 60 FFPE blocks from 1 primary tumor and 2 metastatic sites of each patient were used to make the slides. Five MES-subtype biomarkers, including ACTA2, FAP, POSTN, COL5A1, and VCAN, were selected for immunohistochemistry (IHC) to determine the protein localization and intensities. Two researchers scored tumor sections for intensity as 0 (negative), 1 (weak), 2 (moderate), and 3 (strong), and for localization (stroma/tumor, cytoplasm/nuclear). Statistical analysis was performed using GraphPad Prism 7 software and statistical differences were evaluated using t-test. Results: All 5 proteins evaluated exclusively localized in stroma rather than cancer cells (p&amp;lt;0.001 for all 5 proteins). Only FAP showed significantly different staining intensity between MES and ANM subtype of OC patient samples (p= 0.0114). When comparing primary vs. metastatic sites, only COL5A1 showed significant difference (p=0.019). Conclusion: We report that 5 biomarkers traditionally associated with the MES subtype HGSOC arise from cancer-associated stroma instead of cancer cells. Considering the potential roles of these proteins in mediating HGSOC behavior, it may suggest “stroma targeting” as an alternative therapy to “cancer targeting” to improve OC patient outcomes. Although all 5 genes were reported as MES biomarkers in mRNA-based analysis, we found that FAP was the only protein differentially expressed between MES and ANM subtype suggesting it is a better characteristic biomarker for MES subtype. COL5A1 showed significance in staining between primary and metastatic cancer which may indicates the potential role of COL5A1 in metastasis in OC. Citation Format: Qing Zhang, Kimberly R. Kalli, Chen Wang, William Cliby. The mesenchymal subtype biomarkers arise from stroma rather than cancer cells in ovarian cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4491.